We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.46B
AUM Growth
+$46.3M
Cap. Flow
-$207M
Cap. Flow %
-5.97%
Top 10 Hldgs %
24.55%
Holding
500
New
53
Increased
39
Reduced
236
Closed
55

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$73.4M
2
RHT
Red Hat Inc
RHT
+$66.7M
3
IQV icon
IQVIA
IQV
+$58.8M
4
TGT icon
Target
TGT
+$56M
5
CLGX
Corelogic, Inc.
CLGX
+$40.7M

Sector Composition

Rank Sector Weight
1 Technology 21.56%
2 Consumer Discretionary 17.19%
3 Healthcare 14.91%
4 Industrials 13.28%
5 Communication Services 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIFI
176
DELISTED
Gulf Island Fabrication
GIFI
$736K 0.02%
63,700
-510
-0.8% -$6.29K
GCO icon
177
Genesco
GCO
$419M
$698K 0.02%
+12,580
New +$750K
EXEL icon
178
Exelixis
EXEL
$13.1B
$637K 0.02%
29,380
-30
-0.1% -$610
RARE icon
179
Ultragenyx Pharmaceutical
RARE
$2.64B
$586K 0.02%
8,650
-10
-0.1% -$762
IPAR icon
180
Interparfums
IPAR
$3.83B
$585K 0.02%
16,000
+1,200
+8% +$41.6K
KITE
181
DELISTED
Kite Pharma, Inc.
KITE
$545K 0.02%
6,940
-194
-3% -$12K
BSTC
182
DELISTED
BioSpecifics Technologies Corp.
BSTC
$536K 0.02%
9,788
BRSS
183
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$530K 0.02%
15,420
-83,150
-84% -$2.83M
CVG
184
DELISTED
Convergys
CVG
$502K 0.01%
23,750
-70,590
-75% -$1.66M
SAGE
185
DELISTED
Sage Therapeutics
SAGE
$493K 0.01%
6,940
-10
-0.1% -$586
IRWD icon
186
Ironwood Pharmaceuticals
IRWD
$669M
$488K 0.01%
34,125
-23
-0.1% -$314
CVGI icon
187
Commercial Vehicle Group
CVGI
$134M
$480K 0.01%
70,840
AROC icon
188
Archrock
AROC
$5.81B
$478K 0.01%
38,510
-1,100
-3% -$15.4K
FCBC icon
189
First Community Bankshares
FCBC
$903M
$474K 0.01%
19,000
LNTH icon
190
Lantheus
LNTH
$6.59B
$465K 0.01%
37,170
SYBT icon
191
Stock Yards Bancorp
SYBT
$2.58B
$461K 0.01%
11,335
EXAS
192
DELISTED
Exact Sciences
EXAS
$456K 0.01%
19,320
-20
-0.1% -$396
REX icon
193
REX American Resources
REX
$1.43B
$456K 0.01%
30,240
WRLD icon
194
World Acceptance Corp
WRLD
$871M
$443K 0.01%
8,560
THFF icon
195
First Financial Corp
THFF
$962M
$439K 0.01%
9,250
CLVS
196
DELISTED
Clovis Oncology, Inc.
CLVS
$436K 0.01%
6,840
USPH icon
197
US Physical Therapy
USPH
$1.22B
$433K 0.01%
6,637
WNC icon
198
Wabash National
WNC
$510M
$418K 0.01%
20,192
-3,910
-16% -$76.6K
LGND icon
199
Ligand Pharmaceuticals
LGND
$5.89B
$415K 0.01%
6,284
-16
-0.3% -$1.05K
CASH icon
200
Pathward Financial
CASH
$1.81B
$401K 0.01%
13,590

Similar funds

Smith Group Asset Management's Q1 2017 Portfolio in Review

As of Q1 2017, Smith Group Asset Management held 500 positions worth $3.46B, up 1.4% from $3.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Smith Group Asset Management withdrew a net $207M in Q1 2017, closing 55 positions and reducing 236 holdings. Its most notable exit was Red Hat Inc, an estimated $66.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Smith Group Asset Management opened a new position in Celgene Corp worth $71.3M.

  • Smith Group Asset Management's largest Q1 2017 buy was Celgene Corp: 572,792 shares worth $71.3M.
  • Smith Group Asset Management added most to US Bancorp in Q1 2017, an estimated $22.7M increase.
  • Smith Group Asset Management's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $73.4M.
  • Smith Group Asset Management fully exited Red Hat Inc in Q1 2017, selling an estimated $66.7M.
  • Smith Group Asset Management's ten largest holdings make up 25% of its $3.46B portfolio in Q1 2017.
  • Smith Group Asset Management opened 53 new positions and closed 55 in Q1 2017.
  • Smith Group Asset Management's portfolio value rose 1.4% quarter-over-quarter to $3.46B.

Based on Smith Group Asset Management's 13F filing for Q1 2017, filed 4 May 2017.